Interestingly, examination of transcriptomic (RNA-seq) and methylomic (Infinium methylation assay) data from the Cancer Genome Atlas (TCGA), revealed a significant association between expression of CT-GABRA3 and hypermethylation of the downstream GABRA3 promoter in melanoma (Fig. 1C). Here, GABRA3 is linked to melanoma.